SCHEMBL1574068

SCHEMBL1574068

CS(=O)(=O)Nc1ccc(CC(=O)NO)cc1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.65
HPGD P15428 2/20 0.65
SMN1; SMN2 Q16637 2/20 0.65
ALDH1A1 P00352 1/20 0.65
LMNA P02545 1/20 0.65
HTT P42858 1/20 0.65
HDAC8 Q9BY41 2/20 0.63
HDAC1 Q13547 1/20 0.63
HDAC6 Q9UBN7 2/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
PDE4A P27815 1/20 0.47
HIF1A Q16665 1/20 0.47
HDAC10 Q969S8 1/20 0.47
RECQL P46063 1/20 0.47
EPHX2 P34913 1/20 0.47
NR1H4 Q96RI1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27440295 0.86 HPGD (0.65) KDM4EHPGDSMN1; SMN2ALDH1A1LMNA
SCHEMBL1422207 0.82 ALDH1A1 (0.63) KDM4EHPGDSMN1; SMN2ALDH1A1LMNA
SCHEMBL11195052 0.82 HPGD (0.63) KDM4EHPGDSMN1; SMN2ALDH1A1LMNA
SCHEMBL2693058 0.82 HDAC8 (0.58) KDM4EHPGDSMN1; SMN2ALDH1A1LMNA
SCHEMBL4149990 0.81 HPGD (0.61) KDM4EHPGDSMN1; SMN2ALDH1A1LMNA
SCHEMBL9028983 0.81 HPGD (0.61) KDM4EHPGDSMN1; SMN2ALDH1A1LMNA
SCHEMBL23647680 0.79 SMN1; SMN2 (0.59) KDM4EHPGDSMN1; SMN2ALDH1A1LMNA
SCHEMBL13545194 0.79 KDM4E (0.59) KDM4EHPGDSMN1; SMN2ALDH1A1LMNA
SCHEMBL6014610 0.79 HPGD (1.00) KDM4EHPGDSMN1; SMN2ALDH1A1LMNA
SCHEMBL2691033 0.79 HDAC1 (0.74) HPGDSMN1; SMN2ALDH1A1LMNAHDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013041407-A1 HYDROXAMIC ACIDS AS HDAC6 INHIBITORS CELLZOME AG (DE) 2013-03-28 WO claimed
WO-2013041407-A1 HYDROXAMIC ACIDS AS HDAC6 INHIBITORS CELLZOME AG (DE) 2013-03-28 WO disclosed
WO-2013041407-A1 HYDROXAMIC ACIDS AS HDAC6 INHIBITORS CELLZOME AG (DE) 2013-03-28 WO disclosed
EP-1140085-B1 AZABICYCLOALKANES AS CCR5 MODULATORS PHIVCO UK LTD (GB) 2011-04-13 EP disclosed
US-6586430-B1 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders PFIZER INC. 2003-07-01 US disclosed